Latest Earnings Results: Q3 '26
Estimated EPS
-$0.05
Reported EPS
$0.29
Surprise
+664.52%
Estimated Rev
$725.87M
Reported Rev
$745.65M
Surprise
+2.73%
• Reported GAAP EPS of -$1.13 down -806.25% YoY • Reported revenue of $745.65M down -9.10% YoY • AdaptHealth revised FY2026 guidance: net revenue $2.88B$2.9B (from $2.85B$2.89B), Adjusted EBITDA $510M$525M (from $490M$520M), free cash flow $50M$75M (from $80M$120M).
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.04 | -- | -- | N/A |
Q3 '26 | -$0.05 | $0.29 | 664.52% | BEAT |
Q2 '26 | $0.17 | $0.16 | -5.16% | MISSED |
Q1 '26 | $0.01 | -$0.06 | -545.41% | MISSED |
Q4 '25 | $0.35 | $0.23 | -35.23% | MISSED |